Skip to main content
. 2015 Sep 4;15:118. doi: 10.1186/s12886-015-0106-z

Fig. 1.

Fig. 1

Mean change in best-corrected visual acuity (BCVA) from baseline after each dexamethasone intravitreal implant (DEX implant). Results are shown for patients with retinal vein occlusion who were treatment-naïve at the time of the first DEX implant treatment. a All treatment-naïve patients. b Treatment-naïve patients diagnosed with branch or central retinal vein occlusion (BRVO, CRVO). Numbers in parentheses indicate number (n) of patients included in analysis (all patients with available data). Error bars, standard deviation. *P ≤ 0.034 vs baseline